Results 71 to 80 of about 1,013,993 (235)

Cardiometabolic alterations in the interplay of covid-19 and diabetes: Current knowledge and future avenues [PDF]

, 2021
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) pandemic has raged for almost two years, with few signs of a sustained abatement or remission [...]
Janez A., Rizvi A. A., Rizzo M.
core   +1 more source

Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium

Journal of Virology, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged by the end of 2019 and rapidly spread in 2020. At present, it is of utmost importance to understand the biology of the virus, rapidly assess the treatment potential of existing drugs, and develop new active compounds.
Milewska, Aleksandra, Kula-Pacurar, Anna, Wadas, Jakub, Suder, Agnieszka, Szczepanski, Artur, Dabrowska, Agnieszka, Owczarek, Katarzyna, Marcello, Alessandro, Ochman, Marek, Stacel, Tomasz, Rajfur, Zenon, Sanak, Marek, Labaj, Pawel, Branicki, Wojciech, Pyrc, Krzysztof   +14 more
openaire   +4 more sources

Binding and entering: COVID finds a new home.

PLoS Pathogens, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility ...
Michelle N Vu, Vineet D Menachery
doaj   +1 more source

SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA

Emerging Infectious Diseases, 2021
We report persistent severe acute respiratory syndrome coronavirus 2 infection in a patient with HIV/AIDS; the virus developed spike N terminal domain and receptor binding domain neutralization resistance mutations.
Seth A. Hoffman, Cristina Costales, Malaya K. Sahoo, Srikanth Palanisamy, Fumiko Yamamoto, ChunHong Huang, Michelle Verghese, Daniel A. Solis, Mamdouh Sibai, Aruna Subramanian, Lucy S. Tompkins, Philip Grant, Robert W. Shafer, Benjamin A. Pinsky   +13 more
doaj   +1 more source

SARS-CoV-2–related outcomes after surgical procedures on SARS-CoV-2–positive patients in a large, urban, safety net medical center

Surgery Open Science, 2021
Background: Beginning on March 16, 2020, nonurgent scheduled operations at a large, urban, safety net medical center were canceled. The purpose of this study was to determine complications associated with severe acute respiratory syndrome coronavirus 2 ...
Rachel E. Sargent, MD, Stephen F. Sener, MD, FACS, Rodolfo Amaya, MD, Elizabeth Vazquez, BA, Michael E. Bowdish, MD, MS, FACS, Brad Spellberg, MD   +5 more
doaj  

Bilateral basal ganglia ischemia associated with COVID-19: a case report and review of the literature

Journal of Medical Case Reports, 2021
Background Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2, has a broad clinical spectrum, from asymptomatic to multi-organ dysfunction.
Khurram Khaliq Bhinder, Ahsun Rizwan Siddiqi, Muhammad Junaid Tahir, Hamza Maqsood, Irfan Ullah, Zohaib Yousaf   +5 more
doaj   +1 more source

ICTV Virus Taxonomy Profile:Coronaviridae 2023 [PDF]

, 2023
The family Coronaviridae includes viruses with positive-sense RNA genomes of 22-36 kb that are expressed through a nested set of 3' co-terminal subgenomic mRNAs.
De Groot, Raoul J., Haagmans, Bart, Lau, Susanna K.P., Neuman, Benjamin W., Perlman, Stanley, Sola, Isabel, Van Der Hoek, Lia, Wong, Antonio C.P., Woo, Patrick C.Y., Yeh, Shiou Hwei   +9 more
core   +2 more sources

Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection

Current Opinion in Infectious Diseases, 2021
Purpose of review Despite its crucial role in protection against viral infections, mucosal immunity has been largely understudied in the context of coronavirus disease 2019 (COVID-19). This review outlines the current evidence about the role of mucosal immune responses in the clearance of severe acute respiratory syndrome ...
Fröberg, J., Diavatopoulos, D.A., Diavatopoulos, D.A.   +2 more
openaire   +5 more sources

Experience With Pretravel Testing for SARS-CoV-2 at an Academic Medical Center

Academic Pathology, 2021
International travel has been a significant factor in the coronavirus disease 2019 pandemic. Many countries and airlines have implemented travel restrictions to limit the spread of the causative agent, severe acute respiratory syndrome coronavirus-2.
Katherine L. Imborek MD, Matthew D. Krasowski MD, PhD, Paul Natvig MD, Anna E. Merrill PhD, Daniel J. Diekema MD, Bradley A. Ford MD, PhD   +5 more
doaj   +1 more source

Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019:A Randomized, Controlled Trial [PDF]

, 2022
BACKGROUND: The aim of this randomized, controlled trial is to determine whether antisevere acute respiratory syndrome coronavirus 2 hyperimmune globulin (COVIG) protects against severe coronavirus disease 2019 (COVID-19) in severely immunocompromised ...
Bogers, Susanne, Goorhuis, Abraham, Heijmans, Jarom, Hofsink, Quincy, Huygens, Sammy, Kater, Arnon P., Nijhof, Inger S., Novotný, Věra M.J., Papageorgiou, Grigorios, Rijnders, Bart J., Swaneveld, Francis, Te Boekhorst, Peter A.W., Welkers, Matthijs R.A.   +12 more
core   +1 more source